Zyn's growth trajectory in the U.S. has helped propel Philip Morris International's stock in 2024. Zyn shipments in the U.S. were up over 40% in its fiscal third quarter of 2024, compared to the same ...
On January 17, the FDA authorized ZYNs for sale, claiming their benefit to tobacco users outweighed their risk to the public.